RPRX
Royalty Pharma plc · Healthcare · Medical - Pharmaceuticals
Momentum-inputs (vergelijkbare managers):
breedte van houders -18.8% ·
aandelenstroom -20.9% ·
netto nieuwe posities -20.0%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 146 | 0 | 306.62M | $17.19B | +5 | −4 |
| Q1 2026 | 148 | +6 | 297.67M | $14.26B | +10 | −5 |
| Q4 2025 | 141 | +1 | 305.31M | $11.80B | +2 | — |
| Q3 2025 | 19 | +1 | 173.40M | $6.12B | +2 | −2 |
| Q2 2025 | 16 | 0 | 158.26M | $5.71B | — | — |
| Q1 2025 | 13 | -3 | 61.13M | $1.91B | — | −3 |
| Q4 2024 | 16 | +2 | 77.30M | $1.97B | +2 | — |
| Q3 2024 | 13 | -1 | 62.78M | $1.78B | +1 | −2 |
| Q2 2024 | 14 | — | 58.59M | $1.54B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 13.40M | -5.2% | $417.21M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 13.40M | -5.2% | $417.21M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 13.40M | -5.2% | $417.21M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 13.40M | -5.2% | $417.21M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 5 | Viking Global Investors ✦ | 10.56M | -13.5% | $328.86M | 1.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passief) | 9.52M | -2.5% | $296.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 8.00M | +9.4% | $253.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 8.00M | +9.4% | $253.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 6.25M | -63.2% | $194.56M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 10 | Norges Bank ✦ (passief) | 4.89M | +0.3% | $152.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 2.61M | +37.0% | $80.38M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 2.61M | +37.0% | $80.38M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 2.61M | +37.0% | $80.38M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 2.61M | +37.0% | $80.38M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 2.61M | +37.0% | $80.38M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 2.61M | +37.0% | $80.38M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 2.07M | -28.7% | $64.31M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 2.07M | -28.7% | $64.31M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 1.61M | -33.4% | $50.21M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 1.36M | +103.1% | $42.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Millennium Management ✦ | 309.17K | -87.2% | $9.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 275.84K | -76.2% | $8.59M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 269.46K | +9.3% | $8.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Point72 Asset Management | $6.35M | was 0.0% |
| Bridgewater Associates | $1.26M | was 0.0% |
| Wellington Management | $472,931 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 583 houders, 354.58M aandelen, $16.55B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 100.00K aand · $6.00M
Officer · 9.23K aand · $540,752
Officer · 1.77K aand · $104,799
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
18.7% van klasse · Originele SEC-indiening bekijken ↗
4.8% van klasse · Originele SEC-indiening bekijken ↗